SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193805-23-000633
Filing Date
2023-05-01
Accepted
2023-05-01 16:32:17
Documents
10
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 e618536_def14a-arct.htm DEF 14A 488102
2 GRAPHIC image_001.jpg GRAPHIC 4053
3 GRAPHIC image_004.jpg GRAPHIC 37128
4 GRAPHIC image_006.jpg GRAPHIC 773
5 GRAPHIC image_007.jpg GRAPHIC 773
6 GRAPHIC image_008.jpg GRAPHIC 773
7 GRAPHIC image_005.jpg GRAPHIC 1189
8 GRAPHIC image_009.jpg GRAPHIC 1025
9 GRAPHIC image_010.jpg GRAPHIC 886
10 GRAPHIC image_011.jpg GRAPHIC 34193
  Complete submission text file 0001193805-23-000633.txt   601648
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38942 | Film No.: 23874247
SIC: 2834 Pharmaceutical Preparations